🟢 Gain Therapeutics is trading 5% up in after-hours trading with no clear catalyst identified

Gain Therapeutics is trading 5.12% up at $1.39 in after-hours, with no clear company-specific catalyst identified.

• Shares closed at $1.32 on October 14. The company announced its Maxim Growth Summit participation on October 8, but it is not clearly linked to the move.
• Hotter-than-expected September CPI—3.7% year over year versus 3.6% expected—weighed on markets as major indexes declined. This may be relevant background but does not explain the stock’s opposite-direction after-hours move.